Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosed With Metastatic Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableUnknownNCT05161728
What this trial is testing

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Roderick van den Bergh 150
Testing effectiveness (Phase 2)Ended earlyNCT00019695
What this trial is testing

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerBone MetastasesAdenocarcinoma of the Prostate+1 more
National Cancer Institute (NCI)
Not applicableNo Longer AvailableNCT05002465
What this trial is testing

Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Recurrent
Dana Mathews
Not applicableUnknownNCT03129854
What this trial is testing

Androgen Deprivation Therapy (ADT) Versus ADT Plus Prostate Cryotherapy for Metastatic Prostate Cancer (mPCa)

Who this might be right for
Prostate Cancer Metastatic
Sun Yat-sen University 250
Testing effectiveness (Phase 2)Study completedNCT01120236
What this trial is testing

Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
National Cancer Institute (NCI) 211
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT06922903
What this trial is testing

Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 240
Not applicableStudy completedNCT02236637
What this trial is testing

A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care

Who this might be right for
Prostate Cancer
Janssen Pharmaceutica N.V., Belgium 3,050
Not applicableUnknownNCT04984395
What this trial is testing

Improving Diagnosis and Treatment of Metastatic Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Carcinoma
Royal Marsden NHS Foundation Trust 50
Testing effectiveness (Phase 2)Looking for participantsNCT06854250
What this trial is testing

Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 104
Not applicableNot Yet RecruitingNCT06901492
What this trial is testing

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

Who this might be right for
PSMA PET/CTProstate CancerMpMRI
Nanjing First Hospital, Nanjing Medical University 120
Large-scale testing (Phase 3)Ended earlyNCT04261777
What this trial is testing

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Who this might be right for
Prostate CancerMetastasisProstatectomy
Saving Patients' Lives Medical B.V. 172
Large-scale testing (Phase 3)Study completedNCT02260817
What this trial is testing

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Global Isotopes, LLC d/b/a Zevacor Molecular 109
Testing effectiveness (Phase 2)UnknownNCT05262608
What this trial is testing

The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation

Who this might be right for
Prostate CancerProstate CarcinomaMetastatic Castration-resistant Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30